Technical Analysis for QLI - Qilian International Holding Group Ltd.

Grade Last Price % Change Price Change
D 1.35 -8.16% -0.12
QLI closed down 8.16 percent on Wednesday, February 8, 2023, on approximately normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
20 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
20 DMA Support Bullish -8.16%
200 DMA Support Bullish -8.16%
Wide Bands Range Expansion -8.16%
Gapped Down Weakness -8.16%
200 DMA Support Bullish -4.26%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Qilian International Holding Group Ltd. Description

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings comprising Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to enhance crop yield and soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to enhance plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Disease Health Sciences Medication Pharmacology Cardiovascular Disease Active Pharmaceutical Ingredients Pharmaceutical Sciences Hemodialysis Traditional Chinese Medicine Tablet Licorice Products Liquorice

Is QLI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.165
52 Week Low 0.704
Average Volume 11,787
200-Day Moving Average 1.40
50-Day Moving Average 1.14
20-Day Moving Average 1.35
10-Day Moving Average 1.55
Average True Range 0.17
RSI 51.92
ADX 40.59
+DI 29.43
-DI 23.90
Chandelier Exit (Long, 3 ATRs) 1.62
Chandelier Exit (Short, 3 ATRs) 1.40
Upper Bollinger Bands 1.84
Lower Bollinger Band 0.86
Percent B (%b) 0.5
BandWidth 72.96
MACD Line 0.13
MACD Signal Line 0.14
MACD Histogram -0.0058
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.74
Resistance 3 (R3) 1.73 1.60 1.68
Resistance 2 (R2) 1.60 1.50 1.60 1.65
Resistance 1 (R1) 1.47 1.44 1.41 1.48 1.63
Pivot Point 1.34 1.34 1.30 1.34 1.34
Support 1 (S1) 1.21 1.24 1.15 1.22 1.07
Support 2 (S2) 1.08 1.18 1.08 1.05
Support 3 (S3) 0.95 1.08 1.03
Support 4 (S4) 0.96